A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance

被引：10

作者：

Zaccardi, Francesco ^{[1
]}

Pitocco, Dario ^{[1
]}

Martini, Francesca ^{[1
]}

Caputo, Salvatore ^{[1
]}

Miele, Luca ^{[2
]}

Grieco, Antonio ^{[2
]}

Ghirlanda, Giovanni ^{[1
]}

机构：

[1] Catholic Univ, A Gemelli Hosp, Diabet Care Unit, I-00168 Rome, Italy

[2] Catholic Univ, Inst Internal Med, I-00168 Rome, Italy

来源：

ACTA DIABETOLOGICA | 2014年 / 51卷 / 01期

关键词：

Steatohepatitis; Insulin resistance; Type; 2; diabetes; Drug-induced hepatitis; OBESITY;

D O I：

10.1007/s00592-012-0382-5

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

We describe a case report of a patient who developed transient type 2 diabetes after a drug-induced (esomeprazole) sub-acute hepatitis. This case evidences the pathophysiological relevance, also in humans, of liver inflammation in the pathogenesis of type 2 diabetes.

引用

页码：151 / 153

页数：3

共 13 条

[1]

Acute liver failure [J].

Bernal, William ;

Auzinger, Georg ;

Dhawan, Anil ;

Wendon, Julia .

LANCET, 2010, 376 (9736) :190-201

[2]

Are proton pump inhibitors a new antidiabetic drug? A cross sectional study [J].

Boj-Carceller, Diana ;

Bocos-Terraz, Pilar ;

Moreno-Vernis, Miguel ;

Sanz-Paris, Alejandro ;

Trincado-Aznar, Pablo ;

Albero-Gamboa, Ramon .

WORLD JOURNAL OF DIABETES, 2011, 2 (12) :217-220

[3]

Current concepts: Liver biopsy. [J].

Bravo, AA ;

Sheth, SG ;

Chopra, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :495-500

[4]

Proton Pump Inhibitor Therapy Associated with Lower Glycosylated Hemoglobin Levels in Type 2 Diabetes [J].

Crouch, Michael A. ;

Mefford, Ivan N. ;

Wade, Ekpedeme U. .

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2012, 25 (01) :50-54

[5]

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity [J].

Fabbrini, Elisa ;

Magkos, Faidon ;

Mohammed, B. Selma ;

Pietka, Terri ;

Abumrad, Nada A. ;

Patterson, Bruce W. ;

Okunade, Adewole ;

Klein, Samuel .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (36) :15430-15435

[6]

Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis [J].

Hove, Karin D. ;

Foerch, Kristine ;

Bodvarsdottir, Thora B. ;

Karlsen, Allan E. ;

Petersen, Jacob S. ;

Vaag, Allan .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) :E72-E74

[7]

Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance [J].

Huang, Wan ;

Metlakunta, Anantha ;

Dedousis, Nikolaos ;

Zhang, Pili ;

Sipula, Ian ;

Dube, John J. ;

Scott, Donald K. ;

O'Doherty, Robert M. .

DIABETES, 2010, 59 (02) :347-357

[8]

Kupffer cell activation is a causal factor for hepatic insulin resistance [J].

Lanthier, Nicolas ;

Molendi-Coste, Olivier ;

Horsmans, Yves ;

van Rooijen, Nico ;

Cani, Patrice D. ;

Leclercq, Isabelle A. .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 298 (01) :G107-G116

[9]

Proton pump inhibitors as a treatment method for type II diabetes [J].

Mefford, Ivan N. ;

Wade, Ekpedeme U. .

MEDICAL HYPOTHESES, 2009, 73 (01) :29-32

[10]

Macrophages, Inflammation, and Insulin Resistance [J].

Olefsky, Jerrold M. ;

Glass, Christopher K. .

ANNUAL REVIEW OF PHYSIOLOGY, 2010, 72 :219-246

← 1 2 →